1. All Products
  2. DINJ - Injectable drugs
  3. DOPAMINE hydrochloride, 40mg/ml, 5ml, amp.
Public Pricelist

DOPAMINE hydrochloride, 40mg/ml, 5ml, amp.

https://unicat.msf.org/cat/product/11668
NST DINJDOPA2A-

Valid Article

The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
12.4 - Medicines used in heart failure
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
C01CA04
Anatomical Therapeutic Chemical Classification according to WHOCC
SM
The order of this product needs to be justified and is only acceptable under certain conditions.
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

DOPAMINE

This product became non-standard and should be gradually phased out of the MSF international orders and pharmacy supplies.

Please always consider the MSF STD (noradrenaline) before ordering a NST.

Therapeutic Action

Sympathomimetic agent

Indications

Due to its adverse effects (increased mortality and tachyarrhythmia), dopamine should be gradually replaced by norepinephrine.

Norepinephrine (noradrenaline) remains the vasopressor of choice for cardiogenic and septic shocks.

Some restricted information has been hidden. Sign in to see this information

Instructions for use

Continuous-flow administration of dopamine requires:

  • close medical supervision in hospital setting.
  • use of a dedicated venous line (no other infusions/injections in this line).
  • use of a syringe or infusion pump.
  • gradual increase and adaptation of doses according to clinical response.
  • intensive monitoring of administration, particularly when replacing syringes.

Storage

Below 25ºC - Protect from sunlight